Why is the sharing of data so crucial to #raredisease research? Tune in for today's full episode of Few & Far Between. Episode 10 features Sharon Terry, CEO at Genetic Alliance and #pseudoxanthomaelasticum (PXE) advocate.
How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far...
On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, will be discussing insights into market research solutions for rare...
"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...